Synapse News
McMaster’s Karen Mossman (VPR Research) named one of the 100 Most Powerful Women in Canada
For the two decades she’s been at McMaster, Karen Mossman has forged an international reputation as one of Canada’s finest virologists and emerged as an institutional leader. She was the first woman to hold the position of Chair in the 50-year history of the Department of Biochemistry and Biological Sciences and was the university’s
EmergConnect raises $350,000 to fund emergency room wait time predictor
EmergConnect, a Hamilton startup, has raised $350,000 CAD in what the company classified as an all-equity, SAFE, pre-seed investment round that closed in September. The financing was led by Loyal VC, a global startup index fund, and saw participation from Maple Leaf Angels and Front Row Ventures. With its mission to “revolutionize emergency
McMaster Children’s Hospital ranked one of the best in the world
Children in Hamilton and the surrounding region have access to one of the best pediatric hospitals in the world. Newsweek recently ranked McMaster Children’s Hospital (MCH) within their top 100 pediatric hospitals list – fifth in Canada, and second in Ontario behind Toronto’s SickKids, which was ranked number one in the world.
MedStack secures $3.93 million CAD to capitalize on increased demand for healthtech
Healthcare security, privacy, and compliance startup MedStack has raised $3.93 million CAD ($3.1 million USD) to bolster its offering and support its expansion plans. The all-equity round was led by existing investors Blu Venture Investors (BVI) and Telus Ventures. It saw participation from existing investor Donville Kent Asset Management,
Heads up, future startups: McMaster Seed Fund is now accepting applications
Launched today, the McMaster Seed Fund (MSF), is an early-stage investment vehicle designed to foster innovative startup companies coming out from McMaster research with the potential for significant economic and/or societal impact in the Hamilton region and beyond. Click here for more details on the application process and associated
VoxNeuro receives Health Canada Class II Medical Device designation
VoxNeuro has received Health Canada Class II Medical Device designation for its proprietary Cognitive Health Assessment Management Platform™ (CHAMP). VoxNeuro will begin rolling out the software as a medical device across its Canadian Test Centers. This news comes hot on the heels of VoxNeuro’s FDA registration for the distribution of
SOPHIE gives life science start-ups access to expertise and funds (Healthcare Technology)
A recent federal investment in a Hamilton-based, life science cluster has increased access to expertise and funds for innovative healthcare technology companies – like VoxNeuro. Synapse is a life science cluster that was launched by Hamilton’s regional innovation centre, the Innovation Factory. “Synapse was ready to make the
Ontario Gov’t Invests $860k in Core Print Patterns to Manufacturer Components for COVID-19 Tests
Ontario Together Fund continues to support homegrown innovation and manufacturing to strengthen Ontario’s MedTech ecosystem The Ontario government is investing nearly $860,000 in Coreprint Patterns through the Ontario Together Fund. The investment will help the family-owned-and-operated business manufacture critical components for COVID-19
Fusion Pharmaceuticals to Build 27,000 sqft Radiopharmaceutical Manufacturing Facility in Hamilton
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced it entered a 15-year lease agreement with Hamilton, Ontario-based McMaster University to build a 27,000 square foot current Good Manufacturing Practice (GMP) compliant